Head Lice Infestation Clinical Trial
Official title:
A Randomised, Double-Blind, Vehicle-Controlled Study of Ovicidal Efficacy and Safety of Abametapir 0.74% Administered for the Treatment of Head Lice Infestation
The purpose of the study was to evaluate ovicidal efficacy of a single application of abametapir lotion 0.74% w/w intended for the treatment of head lice.
This was a double-blind, randomised, vehicle-controlled, parallel group study in males and females, aged three years and older with active head lice infestation. The study was designed to assess the ovicidal efficacy of a single application of abametapir lotion 0.74% w/w compared to a vehicle control, when applied to the scalp and hair for 10 minutes at the study site. This study used an ex vivo method of assessment for ovicidal efficacy. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04878276 -
Comparative Head Lice Therapy With Dimet 5® vs. Hedrin® Once
|
||
| Completed |
NCT01907490 -
Safety and PK Study of Ha44 Gel Under Maximal Use Conditions for Treatment of Head Lice Infestation
|
Phase 2 | |
| Completed |
NCT02060903 -
A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
|
Phase 3 | |
| Completed |
NCT02062060 -
Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
|
Phase 3 | |
| Recruiting |
NCT06057506 -
Comparative Study for the Evaluation of Two Medical Devices on the Treatment of Head Lice Infestation
|
N/A | |
| Completed |
NCT02010333 -
A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation
|
Phase 2 |